Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The skeletal dysplasias.

Ravi Savarirayan1, David L Rimoin

  • 1Genetic Health Services Victoria, 10th Floor, Royal Children's Hospital, Parkville 3052, Australia.

Best Practice & Research. Clinical Endocrinology & Metabolism
|December 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

The New England journal of medicine·2026
Same author

Evaluating the impact of vosoritide on complications of achondroplasia.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Effect of vosoritide on spine morphology in children with achondroplasia: 1-year results from a randomized phase 2 study.

Journal of the Endocrine Society·2026
Same author

Effect of vosoritide on genu varum in children with achondroplasia after 1 year in randomized placebo-controlled trials.

Journal of the Endocrine Society·2026
Same author

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

Advances in therapy·2026
Same author

An overview of the International Consensus Statement on achondroplasia.

Orphanet journal of rare diseases·2026
Same journal

Control of muscle mass and accretion.

Best practice & research. Clinical endocrinology & metabolism·2026
Same journal

Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy.

Best practice & research. Clinical endocrinology & metabolism·2026
Same journal

Nutritional advice for patients with obesity and prediabetes.

Best practice & research. Clinical endocrinology & metabolism·2026
Same journal

Effects of prolonged physical training on skeletal muscle mass accrual throughout the life span.

Best practice & research. Clinical endocrinology & metabolism·2026
Same journal

Type 2 diabetes and obesity in South Asian patients with polyendocrine metabolic ovarian syndrome: The emerging role of metabolomics.

Best practice & research. Clinical endocrinology & metabolism·2026
Same journal

Stress and the interaction of the hypothalamic-pituitary-adrenal axis with other pituitary axes and its consequences on muscle mass.

Best practice & research. Clinical endocrinology & metabolism·2026
See all related articles

Skeletal dysplasias are genetic disorders affecting bone development, often causing short stature. Diagnosis integrates clinical, radiographic, and genetic data for precise management.

Area of Science:

  • Genetics
  • Orthopedics
  • Pediatrics

Background:

  • Skeletal dysplasias are a diverse group of genetic disorders impacting bone development and maintenance.
  • These conditions frequently lead to disproportionate short stature and require precise classification.
  • Historically, classification relied on clinical and pathological findings, but now incorporates molecular etiology.

Purpose of the Study:

  • To provide an overview of skeletal dysplasias, encompassing their classification, diagnosis, and management.
  • To highlight the evolution of skeletal dysplasia classification towards molecular genetics.
  • To emphasize the multidisciplinary approach required for accurate diagnosis and patient care.

Main Methods:

  • Comprehensive history taking and longitudinal growth pattern analysis.

Related Experiment Videos

  • Rigorous clinical evaluation of patients and their families.
  • Complete radiographic surveys and, when available, examination of chondro-osseous specimens.
  • Integration of genetic defect identification to link genotype with phenotype.

    • Main Results:

    • The classification of skeletal dysplasias has shifted from descriptive to etiological, incorporating molecular data.
    • Specific genetic defects underlying many skeletal dysplasias are increasingly identified.
    • Established links between genotype and phenotype aid in understanding these conditions.

    Conclusions:

    • Accurate diagnosis of skeletal dysplasias necessitates a combination of clinical, radiographic, and genetic assessments.
    • Management focuses on preventing medical complications, providing psychosocial support, and educating stakeholders.
    • Understanding the molecular basis is crucial for advancing the diagnosis and management of skeletal dysplasias.